DSM-Firmenich AG DSFIR.AS · Stock Open DSM-Firmenich AG in new tab
DSM-Firmenich AG Analysis (DSFIR.AS)
Is DSM-Firmenich AG a good investment? DSM-Firmenich AG (DSFIR.AS) is currently trading at 81.84 EUR. Market analysts have a consensus price target of 85.54 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 68.08. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: DSM-Firmenich AG is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 3.96.
For income investors, DSM-Firmenich AG pays a dividend yield of 2.90%. With a payout ratio of -66%, the dividend appears sustainable.
Investor FAQ
Does DSM-Firmenich AG pay a dividend?
Yes, it pays an annual dividend of 2.50 EUR (2.90% yield).
What asset class is DSM-Firmenich AG?
DSM-Firmenich AG is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 1.21.
Company Profile
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.
| Year | Total Dividends |
|---|---|
| ▸2027 |
2.50 EUR
|
| May 17, 2027 (estimated) | 2.5000 |
| ▸2026 |
2.50 EUR
|
| May 19, 2026 | 2.5000 |
| ▸2025 |
2.50 EUR
|
| May 16, 2025 | 2.5000 |
| ▸2024 |
2.50 EUR
|
| May 16, 2024 | 2.5000 |
| ▸2023 |
1.60 EUR
|
| July 6, 2023 | 1.6000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| DSM-Firmenich AG | May 19, 2026 | Paid | 2.5 EUR |
Community Discussion